SS
AVXL icon

Sunbelt Securities’s Anavex Life Sciences AVXL Stock Holding History

Sunbelt Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83 Buy
+27
New +$117 ﹤0.01% 2696

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sunbelt Securities's AVXL Position: Q1 2026 in Review

Sunbelt Securities opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 27 shares worth $83. The stake represents ﹤0.01% of the portfolio and ranks #2696 among its holdings.

190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Sunbelt Securities held 27 shares of Anavex Life Sciences worth $83 as of Q1 2026.
  • Anavex Life Sciences was a new Sunbelt Securities position in Q1 2026.
  • Anavex Life Sciences made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2696 holding.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.